Skip to content

Effect of residual disease on long term outcomes after coronary intervention

Efffect of residual syntax score and syntax revascularization index on long term cardiovascular outcomes after percutaneous coronary intervention

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ANZCTR
Registry ID
ACTRN12618000833268
Enrollment
250
Registered
2018-05-16
Start date
2018-06-04
Completion date
2018-06-29
Last updated
2018-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Patients with suspected or definite coronary heart disease and were planned to undergo percutaneous coronary intervention between january 2013 and december 2014 will be included in the study. Effect of residual syntax score and syntax revascularization index on cardiovascular outcomes will be studied.

Interventions

Residual significant coronary artery disease after percutaneous coronary intervention (bloooan angioplasty and/or stent imlantation) will be measured by using predefined residual syntax score and syntax revascularization index.. After that the effect of these meausrements on cardiovascular outcomes will be observed for minimum 4 years after the last performed intervnetion

Sponsors

Mustafa Aytek Simsek
Lead SponsorIndividual

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1- Patients over 18 years of age 2- Patients undergone percutaneous coornary interventon due to suspected or definite coronary heart disease including acute coronary syndromes

Exclusion criteria

1- Patients with a history of coronary artery bypass surgery 2- Patienst who are decided to be treated by coronary artery bypass surgery after diagnostic angiography 3- Patients with moderate or severe valvular heart disease 4- Patients with severe left ventricular systolci dysfunction (i.e. left ventricular ejection fraction below 30%) 4- PAatients with sevevre comorbid ilnesses including active malignancies

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026